WGS
GeneDx Holdings Corp.
Latest Form 4:Sale$227KbyFeeley Kevin (CHIEF FINANCIAL OFFICER) · filed Jun 18, 2026
GeneDx Holdings Corp. (WGS) has 49 SEC Form 4 filings (194 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Jun 23, 2026.
The most active filer is CHIEF FINANCIAL OFFICER Feeley Kevin with 18 filings. Insiders have net bought $96.0M over the trailing 6 months. The largest single insider purchase in this window was $20.2M by Director, 10% Owner Meister Keith A. on May 7, 2026.
- Industry:Medical - Diagnostics & Research
- CEO:Katherine A. Stueland
- Employees:1,300
- HQ:Stamford, CT, US
- IPO:2020-11-04
Insider Buying
$106.6M
reported purchases (SEC code P)
Insider Selling
$24.5M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$2.6B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| CHIEF FINANCIAL OFFICER | Sale | 3,729 | $227K | Jun 18 | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 10,501 | $638K | Jun 18 | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 3,639 | $196K | Jun 11 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 1,266 | $68K | Jun 11 | SEC ↗ | |
| Director, 10% Owner | Purchase | 150,000 | $8.5M | Jun 8 | SEC ↗ | |
| Director, 10% Owner | Purchase | 50,000 | $2.6M | Jun 8 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 369 | $19K | Jun 3 | SEC ↗ | |
Casdin Capital, LLCFirst filing | Director, 10% Owner | Purchase | 175,000 | $7.4M | May 20 | SEC ↗ |
Casdin Capital, LLCFirst filing | Director, 10% Owner | Purchase | 185,000 | $7.9M | May 20 | SEC ↗ |
Casdin Capital, LLCFirst filing | Director, 10% Owner | Purchase | 140,000 | $6.1M | May 20 | SEC ↗ |
| Director, 10% Owner | Purchase | 165,000 | $6.4M | May 15 | SEC ↗ | |
| Director, 10% Owner | Purchase | 140,000 | $5.5M | May 15 | SEC ↗ | |
| Director, 10% Owner | Purchase | 46,273 | $1.8M | May 15 | SEC ↗ | |
| Director, 10% Owner | Purchase | 533,758 | $20.2M | May 12 | SEC ↗ | |
| Director, 10% Owner | Purchase | 171,389 | $7.0M | May 12 | SEC ↗ | |
| Director, 10% Owner | Purchase | 500,000 | $19.6M | May 12 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 392 | $26K | May 1 | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 2,172 | $142K | May 1 | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 46,933 | $3.0M | Mar 30 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 8,818 | $557K | Mar 30 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 5,706 | $438K | Mar 17 | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 17,179 | $1.3M | Mar 17 | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 3,678 | $319K | Mar 11 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 1,280 | $111K | Mar 11 | SEC ↗ | |
| Director, 10% Owner | Purchase | 29,495 | $2.1M | Mar 5 | SEC ↗ | |
| Director, 10% Owner | Purchase | 140,026 | $11.4M | Mar 5 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 6,187 | $486K | Mar 5 | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 25,459 | $2.0M | Mar 5 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 287 | $22K | Mar 3 | SEC ↗ | |
| Chief Operating Officer | Sale | 5,961 | $511K | Feb 6 | SEC ↗ | |
Dechairo BryanFirst filing | Chief Operating Officer | Sale | 3,413 | $340K | Feb 3 | SEC ↗ |
| CHIEF FINANCIAL OFFICER | Sale | 317 | $30K | Feb 2 | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 1,653 | $155K | Feb 2 | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 10,857 | $1.6M | Dec 18 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 3,855 | $555K | Dec 18 | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 3,639 | $580K | Dec 11 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 1,266 | $202K | Dec 11 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 377 | $61K | Dec 3 | SEC ↗ | |
RUCH JOSHUAFirst filing | Insider | Sale | 38,000 | $6.1M | Nov 26 | SEC ↗ |
| CHIEF EXECUTIVE OFFICER | Sale | 2,158 | $295K | Oct 31 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 388 | $53K | Oct 31 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 6,609 | $716K | Oct 1 | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 12,858 | $1.4M | Oct 1 | SEC ↗ | |
| CHIEF EXECUTIVE OFFICER | Sale | 10,501 | $1.3M | Sep 18 | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 3,728 | $453K | Sep 18 | SEC ↗ | |
Stueland KatherineFirst filing | Chief Executive Officer | Sale | 3,657 | $468K | Sep 11 | SEC ↗ |
| CHIEF FINANCIAL OFFICER | Sale | 1,272 | $163K | Sep 11 | SEC ↗ | |
Feeley KevinFirst filing | CHIEF FINANCIAL OFFICER | Sale | 378 | $48K | Sep 3 | SEC ↗ |
Related companies
GeneDx Holdings Corp. is in the Healthcare sector.